Search Results - "Mechlovich, Danit"
-
1
The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models
Published in Neuropharmacology (01-09-2017)“…In many of the neurodegenerative diseases, such as Alzheimer's disease (AD) and AD-related disorders, as well as in the regular ageing process, excessive…”
Get full text
Journal Article -
2
Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging
Published in Neurobiology of aging (01-03-2015)“…Abstract Recently, we have designed and synthesized a novel multipotent, brain-permeable iron-chelating drug, VAR10303 (VAR), possessing both propargyl and…”
Get full text
Journal Article -
3
Creation of a gene expression classifier for predicting Parkinson’s disease rate of progression
Published in Journal of Neural Transmission (01-05-2020)“…Parkinson’s disease (PD) etiology is heterogeneous, genetic, and multi-factorial, resulting in a varied disease from a mild slow progression to a more severe…”
Get full text
Journal Article -
4
Molecular targets of the multifunctional iron‐chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus
Published in British journal of pharmacology (01-12-2014)“…Background and Purpose Neurodegenerative diseases are now recognized to be multifunctional, whereby a heterogeneous set of reactions acts independently or…”
Get full text
Journal Article -
5
Molecular targets of the multifunctional iron‐chelating drug, M 30, in the brains of mouse models of type 2 diabetes mellitus
Published in British journal of pharmacology (01-12-2014)Get full text
Journal Article -
6
The novel multi-target iron chelator, M30 modulates HIF-1α-related glycolytic genes and insulin signaling pathway in the frontal cortex of APP/PS1 Alzheimer's disease mice
Published in Current Alzheimer research (01-02-2014)“…Increasing evidence suggests that dysregulation of brain insulin/insulin receptor (InsR) and insulin signaling cascade are associated with the pathogenesis of…”
Get more information
Journal Article -
7
The novel multifunctional, iron-chelating drugs M30 and HLA20 protect pancreatic beta-cell lines from oxidative stress damage
Published in The Journal of pharmacology and experimental therapeutics (01-06-2010)“…Increasing evidence suggests that oxidative stress (OS)-induced pancreatic beta-cell impairments is involved in diabetes and diabetic complications. Our group…”
Get more information
Journal Article -
8
Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism
Published in Journal of Neural Transmission (2013)“…Iron accumulation and iron-related oxidative stress are involved in several pathological conditions and provide a rationale for the development of iron…”
Get full text
Journal Article